179756-58-2
179756-58-2 結構式
基本信息
4-甲基-2- [4- [4-(2-嘧啶基)-1-哌嗪基]丁基] -1,2,4-三嗪-3,5(2H,4H) - 二酮
EPTAPIRONE
F-11440
F11440
4-Methyl-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-1,2,4-triazine-3,5(2H,4H)-dione
4-methyl-2-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-1,2,4-triazine-3,5(2H,4H)-dione
1,2,4-Triazine-3,5(2H,4H)-dione, 4-methyl-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
物理化學性質
| 報價日期 | 產品編號 | 產品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-19946 | F 11440 Eptapirone | 179756-58-2 | 5mg | 495元 |
| 2026/06/05 | HY-19946 | F 11440 Eptapirone | 179756-58-2 | 10mM * 1mLin DMSO | 544元 |
| 2026/06/05 | HY-19946 | F 11440 Eptapirone | 179756-58-2 | 10mg | 822元 |
常見問題列表
|
5-HT 1A Receptor
|
The affinity of Eptapirone (F11440) for 5-HT1Abinding sites (pKi, 8.33) was higher than that of buspirone (pKi , 7.50), and somewhat lower than that of flesinoxan (pKi , 8.91).In vivo, Eptapirone (F11440) was 4- to 20-fold more potent than flesinoxan, and 30- to 60-fold more potent than buspirone, in exerting 5-HT1A agonist activity at pre- and postsynaptic receptors in rats (measured by, for example, its ability to decrease hippocampal extracellular serotonin (5-HT) levels and to increase plasma corticosterone levels, respectively). Eptapirone (F11440), shown here to be a potent, selective, high efficacy 5-HT1Areceptor agonist, appears to have the potential to exert marked anxiolytic and antidepressant activity in humans.[1]